{"id":194557,"name":"TIBER CREEK GROUP (OBO JAZZ PHARMACEUTICALS)","slug":"tiber-creek-group-obo-jazz-pharmaceuticals","state":"CA","country":"United States of America","description":"&#226;€‹Biopharmaceutical company.","totalSpending":1300000,"filings":30,"yearlySpending":[{"year":2019,"income":120000},{"year":2020,"income":120000},{"year":2021,"income":180000},{"year":2022,"income":240000},{"year":2023,"income":240000},{"year":2024,"income":200000},{"year":2025,"income":200000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["TIBER CREEK HEALTH STRATEGIES, INC."],"lobbyists":["JAMES HALL"],"govEntities":["SENATE"],"sampleDescriptions":["Issues related to the Food and Drug Administration and appropriations.","Issues related to the Food and Drug Administration and appropriations.","Issues related to the Food and Drug Administration and appropriations.","Issues related to the FDA and the STATES Act (S. 3032)","Issues related to the FDA and the STATES Act (S. 3032)"]}